KRASG12C Inhibitor, VRTX126 in combination with Tyrosine Kinase Inhibitor, leads to pronounced and effective response in G12C-mutated cancers

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) 2022-10, Vol.174, p.S56-S56
Main Authors: Surampudi, U.K., Bhavar, P.K., Sarma, P.P., Kshirsagar, A.R., Kar, R.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0959-8049
1879-0852
DOI:10.1016/S0959-8049(22)00951-0